Epidemiology of invasive and non-invasive pneumococcal infections in hospitalised adult patients in a Lebanese medical centre, 2006-2015.

J Infect Public Health

Centre for Infectious Diseases Research, American University of Beirut, Riad El-Solh, Beirut, Lebanon; Department of Paediatrics and Adolescent Medicine, Division of Paediatric Infectious Diseases, American University of Beirut, Riad El-Solh, Beirut, Lebanon; Department of Biochemistry and Molecular Genetics, American University of Beirut, Riad El-Solh, Beirut, Lebanon. Electronic address:

Published: December 2020

This is a retrospective medical file review of adult inpatients with Streptococcus pneumoniae infections admitted to a Lebanese hospital between 2006 and 2015. We revisited the clinical scenarios of these infections in view of increasing antibiotic resistance in Lebanon. One hundred and three patients were included; 92% were eligible for pneumococcal vaccination, yet none were vaccinated. Non-invasive pneumococcal disease (non-IPD) represented 64% of these infections. Superinfections caused by antibiotic-resistant bacteria were documented in 17.5% of the patients, with the predominance of ventilator-associated pneumonia (12.6%). Kidney disease and septic shock were positive predictors for mortality [adjusted odds ratio (OR) = 14.96, 95% confidence interval (CI) 2.34-95.45, P = 0.004; OR = 5.09, 95% CI 1.33-19.51, P = 0.02, respectively]. Herein, the differences in clinical success, S. pneumoniae infection-related death, and total mortality were not statistically significant between invasive pneumococcal disease (IPD) and non-IPD subgroups (59.5% vs. 77.3%, P = 0.056; 21.6% vs. 9.1%, P = 0.08; and 35.1% vs. 22.7%, P = 0.174; respectively). Upon comparing antibiotic susceptibility of S. pneumoniae during the first two years of the study (2006-2007) (n = 32 isolates) and the last two (2014-2015) (n = 14 isolates), there was an increasing non-susceptibility to penicillin (34.4%-50.0%, P = 0.25), and a decreasing susceptibility to erythromycin and clindamycin (81.3%-78.6%, P = 0.67 and 90.6%-85.7%, P = 0.65; respectively).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jiph.2019.03.003DOI Listing

Publication Analysis

Top Keywords

non-invasive pneumococcal
8
pneumococcal disease
8
epidemiology invasive
4
invasive non-invasive
4
pneumococcal
4
infections
4
pneumococcal infections
4
infections hospitalised
4
hospitalised adult
4
adult patients
4

Similar Publications

Background: (pneumococcus) causes invasive pneumococcal disease (IPD) and non-invasive acute respiratory infections (ARIs). Three pneumococcal conjugate vaccines (PCVs) are recommended in the United States with additional products in clinical trials. We aimed to estimate 1) proportions of IPD cases and pneumococcal ARIs caused by serotypes targeted by existing and pipeline PCVs and 2) annual U.

View Article and Find Full Text PDF

Background: Despite effective pneumococcal vaccines, pneumococcal disease (PD) exerts a substantial burden on children. This study explored the clinical and economic burden of invasive PD (IPD), non-invasive all-cause pneumonia (ACP), and acute otitis media (AOM) in hospitalized children.

Methods: Data from the BD Insights Research Database of hospitalized children (< 18 years, including infants and children) in the US were analyzed retrospectively.

View Article and Find Full Text PDF

Background: Despite growing evidence of reduced invasive and non-invasive pneumococcal disease attributed to public health measures against the COVID-19 pandemic, the effect of these measures on pneumococcal carriage remains unclear. This study aimed to assess pneumococcal nasopharyngeal carriage among children and adults self-confined at home during the COVID-19 national lockdown in Spain while identifying predictors of pneumococcal carriage in children.

Methods: Household study conducted across the metropolitan area of Barcelona (Spain) between April-June 2020.

View Article and Find Full Text PDF

BackgroundDespite widely implemented pneumococcal vaccination programmes, remains a global risk for human health. can cause invasive (IPD) or non-invasive pneumococcal disease (NIPD). Surveillance is mainly focusing on IPD, assessing the full impact of pneumococcal vaccination programmes on pneumococcal disease is challenging.

View Article and Find Full Text PDF
Article Synopsis
  • Clonal complex 180 (CC180) is the primary strain of serotype 3 Streptococcus pneumoniae, but the 13-valent pneumococcal conjugate vaccine (PCV13) shows limited effectiveness against it, especially regarding its Clades III and IV; this study examined CC180's behavior in Portugal to confirm ongoing patterns seen in other countries.* -
  • An extensive analysis involving whole-genome sequencing of 501 serotype 3 strains from Portuguese patients identified a significant post-PCV13 shift in serotype 3 populations, where Clade I became the most prevalent, displaying higher antibiotic sensitivity and unique genetic traits.* -
  • The findings suggest that Clade I's dominance in Portugal and
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!